Resolute Capital Asset Partners LLC - 10 Oct 2025 SCHEDULE 13G Report for Quoin Pharmaceuticals, Ltd. American Depositary Shares, Each representing thirty-five(35) ordinary shares, no par value per share (QNRX)

Filing Manager
Resolute Capital Asset Partners LLC
Reporting Manager
Resolute Capital Asset Partners LLC
Security
Quoin Pharmaceuticals, Ltd. American Depositary Shares, Each representing thirty-five(35) ordinary shares, no par value per share
Symbol
QNRX
Shares outstanding
588,235 shares
Disclosed Ownership
50,000 shares
Ownership
8.5%
Form type
SCHEDULE 13G
Filing time
11 Dec 2025, 10:10:03 UTC
Date of event
10 Oct 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Resolute Capital Asset Partners LLC disclosed 8.5% ownership in Quoin Pharmaceuticals, Ltd. American Depositary Shares, Each representing thirty-five(35) ordinary shares, no par value per share (QNRX) on 10 Oct 2025."

Quick Takeaways

  • Resolute Capital Asset Partners LLC filed SCHEDULE 13G for Quoin Pharmaceuticals, Ltd. American Depositary Shares, Each representing thirty-five(35) ordinary shares, no par value per share (QNRX).
  • Disclosed ownership: 8.5%.
  • Date of event: 10 Oct 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 11 Dec 2025, 10:10.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Resolute Capital Asset Partners LLC 8.5% 50,000 0 50,000 ANITA FALICIA CHIEF COMPLIANCE OFFICER
Resolute Capital Asset Partners Fund I LP 8.5% 50,000 0 50,000 ANITA FALICIA CHIEF COMPLIANCE OFFICER

Sponsored